Atrium Therapeutics, Inc. (RNA)

Nasdaq · Pharmaceutical Preparations · Inc. DE

What they're doing

Not enough recent activity to summarise.

Signals, last 12 months

  1. Material 8-K filing
    Filed 8-K disclosing material agreement, director or officer change

Insider transactions

DateInsiderRoleCodeSharesPriceValue
2026-09-18Hoyos Rocio MartinofficerF8,3208.95$74,464
2026-09-18Winslow Brendan R.officerF6,7428.95$60,341
2026-09-18Gallagher Kathleen P.directorF11,6328.95$104,106
2026-09-18Kenney StephanieofficerF2,3758.95$21,256
2026-09-18Boyce SarahdirectorF126,4188.95$1,131,441
2026-09-18Flanagan W. MichaeldirectorF22,8128.95$204,167
2026-09-18Hughes Steven GeorgeofficerF21,4598.95$192,058
2026-09-18Younis HusamofficerF11,2168.95$100,383
2026-04-20Younis HusamofficerA30,0000$0
2026-04-20Hoyos Rocio MartinofficerA30,0000$0
2026-04-20Gallagher Kathleen P.directorA102,5000$0
2026-04-20Winslow Brendan R.officerA30,0000$0
2026-04-20Hughes Steven GeorgeofficerA30,0000$0
2026-04-20Kenney StephanieofficerA30,0000$0
2026-04-20Kenney StephanieofficerA30,0000$0
2026-04-20Hughes Steven GeorgeofficerA30,0000$0
2026-04-20Winslow Brendan R.officerA30,0000$0
2026-04-20Gallagher Kathleen P.directorA102,5000$0
2026-04-20Hoyos Rocio MartinofficerA30,0000$0
2026-04-20Younis HusamofficerA30,0000$0

Federal contracts

No federal contract actions on record for this recipient mapping.

Lobbying

No federal lobbying filings on record for this client mapping.

Public attention

No Wikipedia pageview data linked to this company.

Recent filings